Pharmaceutical - Lonza

Filter

Current filters:

Lonza

Popular Filters

Ipsen expects Increlex supply interruption; 1st-qtr sales up 5.3%

25-04-2013

French drugmaker Ipsen (Euronext: IPN) says that its supplier of Increlex (mecasermin [rDNA origin] Injection)…

FinancialIncrelexIpsenLonzaPharmaceuticalProduction

Lonza and Agennix link up for talactoferrin production

12-04-2012

Switzerland-based Lonza (SIX: LONN) and Agennix AG (FSE: AGX) of Germany have announced an agreement…

AgennixBiotechnologyLonzaOncologyPharmaceuticalResearchtalactoferrin

Mesoblast and Lonza establish strategic global manufacturing alliance for stem cell products

28-09-2011

Australian regenerative medicine company Mesoblast (ASX: MSB) and Switzerland-based Lonza Group (SWS:…

BiotechnologyLicensingLonzaMesoblastPharmaceutical

Back to top